Comparison of ThermoCool® Surround Flow Catheter Versus ThermoCool® Catheter in Achieving Persistent Electrical Isolation of Pulmonary Veins: A Pilot Study

Persistent Electrical Isolation of Pulmonary Veins . Introduction: Aim of this study was to compare efficacy and safety of the new ThermoCool Surround Flow® catheter (SFc) versus the ThermoCool® (TCc) in achieving persistent circumferential electrical isolation of the pulmonary veins (PVs) in patients with paroxysmal atrial fibrillation (AF). Methods and Results: This multicenter, randomized, controlled study enrolled patients suffering from paroxysmal AF. Randomization was run in a one‐to‐one fashion between radiofrequency ablation by TCc or SFc. Aim of PVs ablation was documentation of electrical isolation with exit/entrance block recorded on a circular catheter. Among the 106 enrolled patients, 52 (49.0%) were randomized to TCc and 54 (51.0%) to SFc. Total volume of infused saline solution during the procedure was lower in the SFc than in TCc group (752.7 ± 268.6 mL vs 1,165.9 ± 436.2 mL, P < 0.0001). Number of identified and isolated PVs was similar in the 2 groups. Number of PVs remaining isolated 30 minutes after ablation was higher in the SFc than in TCc group (95.2% vs 90.5%, P < 0.03), mainly driven by acute ablation result in the left PVs (96.1% vs 89.7%, P < 0.04). Complications were seldom and observed only in the TCc group (0% vs 3.84%, P < 0.03). At 6‐month follow‐up SFc patients reported a trend toward less AF recurrences compared to those in the TCc group (22.9% vs 27.0%, P = 0.69). Conclusion: PV isolation by SFc lowered the rate of left PV early reconnections and reduced the volume of infused saline solution while maintaining the safety profile of AF ablation. (J Cardiovasc Electrophysiol, Vol. 24, pp. 269‐273, March 2013)     

Monocytes/macrophages infected with Toxoplasma gondii do not increase co‐stimulatory molecules while maintaining their migratory ability

Toxoplasma gondii is an obligate intracellular parasite that is able to disseminate into deep tissues and cross biological barriers, reaching immunoprivileged sites such as the brain and retina. The parasite is able to infect macrophages and dendritic cells and use them for dispersal throughout the body, but the activation state of those cells is unknown. We investigated the ability of human and murine cells from monocytic/macrophage lineages that had not previously been exposed to inflammatory cytokines to up‐regulate co‐stimulatory and adhesion molecules upon infection. Toxoplasma gondii‐infected human monocytes (freshly isolated and THP1 lineage) were unable to up‐regulate CD86, CD83, CD40 or CD1a. CD80 expression increased in infected cells but expression of l ‐selectin and β2 integrin was unaltered. We evaluated the ability of infected macrophages from wild type C57/BL/6 or CD14^?/? mice to migrate in 8 μm transwells. Infected cells from CD14^?/? mice were more likely to de‐adhere than infected cells from wild type mice but they did not show any increase in migratory ability. The non‐stimulatory profile of these infected cells may contribute to parasite spread throughout the lymphatic circulation in the initial phases of infection.     

Efficacy of Ivabradine in a Case of Inappropriate Sinus Tachycardia and Ventricular Dysfunction

Ivabradine in IST . We present a case of a 49‐year‐old man with inappropriate sinus tachycardia and ventricular dysfunction. The conventional treatment (ace‐inhibitor and beta‐blockers) was not well tolerated by the patient, so Ivabradine, a specific inhibitor of If current in the sinus node, was started. After 3 months of using this medication, we observed an improvement of ejection fraction and quality of life. (J Cardiovasc Electrophysiol, Vol. pp. 815‐817, July 2010)     

BAYESIAN IMPUTATION OF PREDICTIVE VALUES WHEN COVARIATE INFORMATION IS AVAILABLE AND GOLD STANDARD DIAGNOSIS IS UNAVAILABLE

We suggest a conceptually simple Bayesian approach to inferences about the conditional probability of a specimen being infection-free given the outcome of a diagnostic test and covariate information. The approach assumes that the infection state of a specimen is not observable but uses the outcomes of a second test in conjuction with those of the first, that is, dual testing data. Dual testing procedures are often employed in clinical laboratories to assure that positive samples are not contaminated or to increase the likelihood of correct diagnoses. Using the CD4 count and a proxy for risk behaviour as covariates, we apply the method to obtain inferences about the conditional probability of an individual being HIV-1 infection-free given the individual's covariates and a negative outcome with the standard enzyme-linked immunoadsorbent assay/Western blotting test for HIV-1 detection. Inferences combine data from two studies where specimens were tested with the standard and with the more sensitive polymerase chain reaction test.     

A BIVARIATE PARAMETRIC MODEL FOR SURVIVAL AND INTERMEDIATE EVENT TIMES

In diseases such as acquired immune deficiency syndrome (AIDS), there is great interest in describing the frequency of secondary diagnoses that occur during the course of the disease and their effect on survival. Casting this situation in a more general framework, one distinguishes a terminal event (TE) and an intermediate event (IE) that may or may not occur. In epidemiologic applications the TE is usually death. Earlier studies of IE and TE times have used the latter to censor the IE time for individuals who do not present it. For such cases, we argue that more appropriately the TE removes the individual from the risk set for the IE. With this view, one distinguishes observations of four types, each with a different formula for its likelihood contribution. We propose an approach that uses separate parametric models for the marginal distribution of the survival time D and for the conditional distribution of the time R to the IE given D = d and R⩽D. A central quantity is the probability of presenting the IE given the occurrence of the TE at time d. This function of d can reveal important connections between the two events. We suggest a model derived from Weibull distributions where the parameters control the shape of this function. One can obtain inferences about other probabilities of interest such as the proportion of individuals who present the IE, P(R⩽D), the marginal distribution of R among the IE cases, P(R>r∣R⩽D) and the residual survival after the IE occurs, P(D−R>v∣R⩽D, R = r). We apply the model to the analysis of time to secondary Kaposi's sarcoma (KS) diagnosis and time to death in a large cohort study of homosexual men infected with the human immunodeficiency virus type 1 (HIV) and who had an initial non-KS AIDS diagnosis.     

Long-term use of dentine adhesive as an interfacial sealer under Class II amalgam restorations

An in vitro study was carried out to evaluate the long-term sealing properties of a light-cured dentine adhesive in Class II amalgam restorations. The restorations were subjected to repeated vertical occlusal loads and a number of thermocycling procedures. The results demonstrated significant advantages of using a dentine adhesive as an interfacial sealer in order to reduce microleakage, compared to a conventional Copal varnish.